Colorectal Cancer        

FOI REFERENCE: 24219  FOI DATE: 11^th July 2024      

In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens?

Can you please provide the total number of patients treated for CRC with each product and the total number of Metastatic patients treated with each product for CRC in the table below

Regimens	Total CRC Patients
Aflibercept plus chemotherapy	0
Bevacizumab plus fluoropyrimidine-based chemotherapy	*
Capecitabine	19
CAPIRI	*
CAPOX	56
Cetuximab with FOLFIRI	0
Cetuximab with FOLFOX	0
Cetuximab as a single agent	14
Cetuximab with Encorafenib	7
Irinotecan as a single agent	71
FOLFIRI	*
FOLFOX	8
Fluorouracil (5FU) as a single agent	*
Oxaliplatin as a single agent	36
Nivolumab with Ipilimumab	0
Panitumumab with FOLFIRI	0
Panitumumab with FOLFOX	0
Panitumumab as a single agent	18
Pembrolizumab	13
Any other systemic anti-cancer therapy	Not applicable
Palliative care only	150

*This relates to low numbers between 1 and 5. Under section 40 (ii) of the Freedom of Information Act 2000, statistically low numbers that potentially identify personal data are required to be withheld because of the Trusts obligation to protect personal data under the Data Protection Act 2018.